Lamotrigine

Lamotrigine, commonly used to treat mood disorders like bipolar disorder, is the focus of several clinical trials aiming to understand its effectiveness, safety, and adjustments required in specific conditions. This article summarizes key findings and objectives from five different clinical trials involving Lamotrigine, ranging from assessments of its long-term use, effects in specific demographics like pregnant women, and its bioequivalence in chewable tablet form.

Table of Contents

What is Lamotrigine?

Lamotrigine is a medication used to treat various neurological and psychiatric conditions. It is known by several brand names, including Lamictal, Lamiktal, Labileno, and Crisomet[1][2][3]. Lamotrigine belongs to a class of drugs called anticonvulsants or antiepileptics, which are primarily used to prevent seizures. However, it has also been found effective in treating mood disorders.

What Conditions Does Lamotrigine Treat?

Lamotrigine is approved and used for several conditions:

  • Bipolar Disorder: Lamotrigine is particularly effective in treating bipolar depression, which is the depressive phase of bipolar disorder. It can help prevent mood episodes in people with bipolar I and bipolar II disorder[1][4].
  • Epilepsy: While not explicitly mentioned in the provided trials, lamotrigine is widely used as an antiepileptic medication to prevent seizures.
  • Major Depressive Disorder: Some studies have explored the use of lamotrigine in treating major depression, especially when it hasn’t responded well to other treatments[2].
  • Schizoaffective Disorder: This condition, which combines features of schizophrenia and mood disorders, may also be treated with lamotrigine in some cases[2].

How Does Lamotrigine Work?

Lamotrigine works by stabilizing electrical activity in the brain. It does this by blocking certain channels that allow the movement of sodium ions in brain cells. This action helps prevent the excessive electrical discharges that can lead to seizures or contribute to mood instability. In mood disorders, lamotrigine is thought to help balance neurotransmitters, the chemical messengers in the brain, which can help stabilize mood and prevent depressive episodes[4].

Dosage Forms and Administration

Lamotrigine comes in several forms:

  • Immediate-release tablets: These are taken once or twice daily[1].
  • Extended-release tablets: These are designed to release the medication slowly over time and are usually taken once daily[5][6].
  • Chewable/dispersible tablets: These can be chewed or dissolved in liquid, which may be helpful for people who have difficulty swallowing pills[7][8].

The dosage of lamotrigine can vary widely depending on the condition being treated, other medications being taken, and individual patient factors. It’s typically started at a low dose and gradually increased over several weeks to reduce the risk of side effects[1].

Potential Side Effects

Like all medications, lamotrigine can cause side effects. Common side effects may include:

  • Dizziness
  • Headache
  • Double vision or blurred vision
  • Nausea
  • Sleepiness
  • Skin rash

It’s important to note that while most side effects are mild, lamotrigine can occasionally cause a serious skin rash. This is rare but can be life-threatening if not addressed promptly. Patients should seek immediate medical attention if they develop any unusual rash while taking lamotrigine[1].

Use in Special Populations

Pregnancy: Lamotrigine is often used to treat bipolar disorder in pregnant women. However, pregnancy can affect how the body processes lamotrigine, potentially leading to lower blood levels of the drug. This may require dose adjustments during pregnancy to maintain effectiveness. After delivery, lamotrigine levels may increase again, necessitating another dose adjustment[9][2].

Bariatric Surgery Patients: People who have undergone bariatric (weight loss) surgery may process lamotrigine differently. This is because the surgery can affect how drugs are absorbed in the digestive system. If you’ve had bariatric surgery or are planning to have it, your doctor may need to monitor your lamotrigine levels more closely[3].

Drug Interactions

Lamotrigine can interact with other medications. Some drugs can increase or decrease the levels of lamotrigine in your body:

  • Inducers: Some medications, like carbamazepine, can increase the breakdown of lamotrigine in your body, potentially making it less effective[9].
  • Inhibitors: Other drugs, like valproate, can slow down the breakdown of lamotrigine, potentially increasing its levels and the risk of side effects[9].

Always inform your healthcare provider about all medications you’re taking, including over-the-counter drugs and supplements.

Monitoring During Treatment

While taking lamotrigine, your doctor may recommend regular check-ups and blood tests to monitor:

  • Lamotrigine levels in your blood
  • Liver function
  • Kidney function
  • Complete blood count

These tests help ensure that you’re receiving the right dose and that the medication isn’t causing any unexpected effects on your body[1][9].

Remember, while this information provides a general overview, always consult with your healthcare provider for personalized advice about taking lamotrigine. They can provide guidance tailored to your specific health needs and circumstances.

Trial Name Description Study Type Phase Participants Primary Focus URL
NCT00566020 Long-term evaluation of lamotrigine in bipolar I disorder. Interventional Phase 3 92 Safety Link
NCT00475137 Effectiveness of lamotrigine alone vs with antidepressant for bipolar II depression. Interventional Phase 2 15 Efficacy Link
NCT01996293 Lamotrigine use in pregnant women with bipolar disorder. Observational 30 Pharmacokinetics Link
NCT03497143 Impact of bariatric surgery on lamotrigine pharmacokinetics. Observational 12 Pharmacokinetics Link
NCT01131975 Bioequivalence of 25 mg lamotrigine chewable tablets. Interventional Phase 1 26 Bioequivalence Link

Ongoing Clinical Trials on Lamotrigine

  • Study Comparing Lithium and Lamotrigine for Mood Stabilization in Patients with Bipolar Disorder Type II

    Recruiting

    1 1 1 1
    Investigated diseases:
    Denmark
  • Study on Enhanced Treatment for Schizophrenia, Depression, and Bipolar Disorder Using Esketamine, Bupropion, and Quetiapine for Patients with Initial Treatment Failure

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Austria Germany Italy Spain
  • Study on the Effectiveness and Safety of AP707 with Lamotrigine and Amitriptyline for Patients with Chronic Central Neuropathic Pain

    Not recruiting

    1 1 1
    Investigated diseases:
    Austria Germany

Glossary

  • Bipolar Disorder: A mental health condition characterized by extreme mood swings, including emotional highs (mania or hypomania) and lows (depression).
  • Pharmacokinetics: The study of how drugs move through the body, including absorption, distribution, metabolism, and elimination.
  • Bioequivalence: A term used to describe when two drugs have similar bioavailability and produce the same effect at the site of physical activity.
  • Montegomery-Asberg Depression Rating Scale (MADRS): A ten-item diagnostic questionnaire used to measure the severity of depressive episodes in patients with mood disorders.
  • Prospective Study: A type of study that follows participants forward in time to monitor outcomes as they occur.

References

  1. https://clinicaltrials.gov/study/NCT00566020
  2. https://clinicaltrials.gov/study/NCT03774641
  3. https://clinicaltrials.gov/study/NCT03497143
  4. https://clinicaltrials.gov/study/NCT00475137
  5. https://clinicaltrials.gov/study/NCT01888757
  6. https://clinicaltrials.gov/study/NCT01888263
  7. https://clinicaltrials.gov/study/NCT01131975
  8. https://clinicaltrials.gov/study/NCT01131949
  9. https://clinicaltrials.gov/study/NCT01996293